|

Autologous CD19-Targeted CAR-T Cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Vinmec Research Institute of Stem Cell and Gene Technology1

Indications

  • Refractory Systemic Lupus Erythematosus1
  • Lupus1

Other1 trial

CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.